TickrTrends PFE fair value analysis

Pfizer (PFE) Pays Out Over 226% of Earnings and Trades at 36.7x Trailing Against 9.8 Forward. What Is the Yield Telling You?

insidermonkey.com · 2026-10-13

Pfizer Inc. (NYSE:PFE) closed at $28.40 on October 12.

TickrTrends take: Pfizer's dividend payout ratio exceeds its earnings, which typically signals either unsustainable distributions or management confidence in future cash generation, a dynamic worth monitoring alongside its valuation metrics. The company's trailing price-to-earnings multiple substantially exceeds its forward multiple, suggesting the market may be pricing in significant earnings growth or operational improvements ahead. Given TickrTrends' overvalued designation for PFE in the Healthcare sector, investors should track whether the company can narrow the gap between these multiples through actual earnings expansion or if the valuation premium continues to widen.

Read the full story at insidermonkey.com →

Is PFE undervalued? See TickrTrends' fair value analysis →